*****This thread is setup mainly to gain information
relating to Mediwatch in a quick and easy way and IS IN NO WAY A
RECOMMENDATION TO BUY!********


Mediwatch-A Synopsis:
Mediwatch was established in 1996 and has developed a range of specialist
medical equipment for the diagnosis of urological disorders.The group joined the
AIM in 2000 through a reverse into Prostcare plc,which at the time was valued at
8m.While the vast majority of sales were generated in the UK,there was a
substantial indirect export business involving a number of agents,supplying into
Europe,North America,Australasia and Asia,notably Japan.
Group revenues are set to increase rapidly following the acquisition of the former
Medtronic Urodynamis Division,which has introduced a fundamental presence in
North America.The deal was in 2006 with the sales division building from 2007.
With the inclusion of the Medtronic systems now owned by Mediwatch they now
can offer a 'One Stop Shop' for the diagnosis of various urology disorders with the
benefit of Mediwatch systems having the ability to electronically send data from the
various tests to a central data base!Oh and plus the added bonus of PSAwatch and
now PCA3plus!

More than 30 million PSA tests are performed annually in the USA alone!

CHARTS

FUTURE EVENTS AND LATEST
NEWS

Just for the record and to even things up,this is Treblewide's view (near end
of 2008):

"in short 3p by chrimbo and a real chance if they do not get rid of management they
will go into receivership.....when they bough the MDT business I said at the time it
must have been a bag of shite as they only paid buttons for it.......looks like that was
fairly correct......i feel sorry for shareholders"

Treblewide has been filtered from my eyes for his abuse,lies and general behavior but
it's a free country (I think) so do as you see fit.


It started with:

Treblewide - 05 Jun 2007 15:49 - 33 of 1747
still short

Treblewide - 18 Jun 2007 00:24 - 69 of 1747
interesting stuff from that article...very few men die from prosate cancer and it is not an agressive disease....treatment can be worse than the disease.......kind of suggests their whole business model is based on sand to me.......but hey who wants a balanced view.

Treblewide - 18 Jun 2007 00:31 - 76 of 1754
exercise and sex may cause a raised PSA...so you guys may have stumbled on a test for fit shaggers :-)

I am gonna name Me-Di-Watch

Gonna-go-bust-soon-iwatch

Treblewide - 18 Jun 2007 10:59 - 85 of 1754
minder...i do not make light of prosate cancer....show me one post where I do...i make fun out of this company yes but not the disease so wind yer neck in pal.

show me any trace of a profit and i will maybe change my mind

Treblewide - 18 Jun 2007 15:54 - 97 of 1754
minder made a small loss yes which I have more than made up for shorting it........and i guess your average holding is 3p.....aye right.

Aalso I closed out my short at 8p for a loss of the spread if memory serves me correctly.

currently short from 13.25....i thank you and goodnight

Treblewide - 23 Jul 2007 12:36 - 154 of 1747
more of the same......thank god i still do not own shares in this lot...will they ever
make a penny profit....looks doubtful......cannot even manage a small supply chain.


ect ect ect

with the last few posts:

Treblewide - 30 Mar 2009 09:16 - 1704 of 1754
you are a lunatic mick.....words fail me.

and ps i only post under treblewide on any financial web site....i know you cannot say the same......you have been calling this as a buy and nothing but a buy for about 7 years...it says it all really about your stock picking ability

i notice the downtrend ins now establishing itself....re-visit of the lows again by the looks of things

Treblewide - 30 Mar 2009 22:41 - 1712 of 1754
mick no i dont know what each product does...i dont think that is important...the numbers tell everything and even though you must spend hours on web sites searching for stuff that is not even related to MDW you fail to grasp the basics...they consistently lost money and now seem to be making some...my call to 3p was correct and i think if they had not got their shit together they could have gone under

i was not interested in them as a long play while they were loosing money depsite whatever rubbish you posted regarding piss sticks or whatever you bang on about.

and yes it was poor trading..having an avergae of 12 and averaging down to 6-7p while they were at 3p....is terrible trading...that cannot even be debated...the very fact you know so much about the products means you have fallen in love with this company......which is very dangerous when investing....

the numbers are the important things...i was right on 3p, the company is posting slightly better figures but we are in a bear market which has not bottomed yet so the price will fall further

you are a 1 trick pony that posts irrelevant links...dont bother to respond i can be bothered getting into a debate with you.....away and cut and paste some more flags

toodlepip

**************************************************************

I have been chased from here and now ADVFN,has the boy got a problem?

treblewide - 3 Aug'09 - 14:46 - 22345 of 22412


post 22342 is classic.....so mick advfn is not a good source when the consensus is sell?

begs the question why you spend so much time polluting it with your bull tripe?

question....so MDW share price has gone up, it has gone down etc etc...during all of that time has mick ever been able to find any subjectivity in his posting ie has he ever critisised anything?

i really think he may be getting paid by MDW...the whole thing is very bizzare.

mick i notice you referred to your threads as "promotion of Mediwatch"

can you confirm if you are getting financially rewarded by the company for this?

treblewide - 3 Aug'09 - 23:55 - 22371 of 22412


664k overdrawn....takes a long time to pay back at 39k profit every 6 months.

drawn down overdraft has increased by 170k and they paid 33k to service that overdraft and made 39k profit...as i keep saying my local fish and chip shop make more money than this lot.

margins have been squeezed...psa watch now off the agenda in terms of updates....not 1 single reason to buy and yet you lot think this share price will go up??.....am mystified why it would increase? genuinely why is this comapny under valued?? i cannot see it and dont bang on about fairfax saying they are going to make x amount...they have never been near to getting it right

if i were a holder i would be selling now at 6p if i could and buying back in the 2-3p range which the chart is saying is now a certainty....i expecta full year loss

i told you all to sell at 14p and at 11p (it is all there in black and white) and that it was going to 3 pence..i got abuse mick called me an idiot and suggested it was going to 50p......still a sell and my short (which was posted in real time over the road) is nicely in profit.

toodle pip...will log back in when it gets to 3p....



treblewide - 4 Aug'09 - 00:19 - 22373 of 22412


664k overdrawn....takes a long time to pay back at 39k profit every 6 months.

drawn down overdraft has increased by 170k and they paid 33k to service that overdraft and made 39k profit...as i keep saying my local fish and chip shop make more money than this lot.

margins have been squeezed...psa watch now off the agenda in terms of updates....not 1 single reason to buy and yet you lot think this share price will go up??.....am mystified why it would increase? genuinely why is this comapny under valued?? i cannot see it and dont bang on about fairfax saying they are going to make x amount...they have never been near to getting it right

if i were a holder i would be selling now at 6p if i could and buying back in the 2-3p range which the chart is saying is now a certainty....i expecta full year loss

i told you all to sell at 14p and at 11p (it is all there in black and white) and that it was going to 3 pence..i got abuse mick called me an idiot and suggested it was going to 50p......still a sell and my short (which was posted in real time over the road) is nicely in profit.

toodle pip...will log back in when it gets to 3p....

treblewide - 4 Aug'09 - 10:49 - 22379 of 22412


still time to get out at 6p.....dont understand why you would not sell at 6p when they are obviously going to half in value...if you are a long term mdw bull you can buy twice as many shares at 3p and maybe possibly one day see a profit on your holding?



treblewide - 4 Aug'09 - 12:44 - 22381 of 22412


last chance to sell at 6p for your shares folks


treblewide - 4 Aug'09 - 14:48 - 22387 of 22412


so question...is psawatch is so great...why has there been no huge surge in revenue figures from UK and Europe on the back of it being sold?

the whole reason a lot of you hold this is psawatch...it has not made them any money in Europe which could be argued when taken as a whole is not much smaller than the USA.....this company is not going to change overnight with US approval...at bets it would be a selling opportunity for long term holders

i really think a lot of you have to ignore some of the nonsense ramping going on here...the company is draining cash and there margins are reducing (despite this wonder PSA machine they have for sale)

i really think the future looks bleak for mediwatch...if someone can put in concise terminology why MDW is a buy i am all ears....dont point me at fairfax report...they are a bunch of clowns as well...that interim report is shocking and i mean really poor.

costs out of control...margins squeezed, cash running out...no real revenue growth, does this sound like a growth company to you?

sell at 6p


treblewide - 4 Aug'09 - 15:50 - 22391 of 22412


god i have heard it all now...mick can you counter my points about declining margins and cash issues without nonsense posts about peopel having insider information...what a crock and what a clown.

so just so i have this straight in my head...when you put in effort to ramp these shares it is all great and you expect cuddles? (and if anyone disagrees you throw your toys out the pram liek an old woman)

when i put up a few posts to explain why i am short it is an organised attempt to get the share price down because i have insider inforamtion from the US?

were you the Iraqi information minister in a previous role? lol


treblewide - 5 Aug'09 - 19:24 - 22409 of 22412


lol.....shares getting sold today at 5.75.....next stop 3p...

treblewide - 4 Aug'09 - 12:44 - 22381 of 22408 edit


last chance to sell at 6p for your shares folks




treblewide - 5 Aug'09 - 19:29 - 22410 of 22412


i wonder what thier overdraft is limited to....1M?

if so they have 12 months of life left at current perfomance...how many of you hlders have considered the chances of them going bust?....i would not rule it out...would love to know how much further the banks will let them go into debt before they pull the plug

treblewide - 5 Aug'09 - 19:37 - 22411 of 22412


seriously if i were a holder i would look at the interims and ask how much longer can they go on burning cash.......and with all the averaging down the bulls have done over the years i bet some are more exposed than they should be....good luck...think you might need it




ANYWAY

http://mediwatch.blogspot.com/

On the 16th of March 2009, the eyes of the UK's healthcare sector will be on Central London, for the unveiling of the Medilink UK Awards 2009.

http://www.medilinkuk.com/events/display.php?id=413&crumb=National%20Events

Previous news:


The Cream of the UK Healthcare Technology Sector is Announced

The Medilink UK Awards, sponsored by Xiros Plc, celebrate cutting edge technologies, outstanding business achievements and international success and collaboration and have been designed to showcase the cream of the healthcare industry.

Held at Haberdashers Hall, London on Monday 16th March, the Medilink UK Awards 2009 is being run in association with UK Trade & Investment (UKT&I), Health Technologies KTN, BERR (Department for Business Enterprise and Regulatory Reform, the NHS National Innovation Centre (NIC) and NIHR (National Institute for Health Research).

The nominees for each of the five awards Export Achievement, Innovation, Growth in Sector, Partnership with the NHS and Start Up - are made up of regional winners from the Medilink Awards and are selected by a panel of sector specialists from the 12 UK regions.

All the winners will be announced on the day and there will also be speeches from a wide range of specialist from across the healthcare industry.

The nominees for this years awards include:

Export Achievement Award (sponsored by UKT&I) - IDS Ltd, Mediwatch UK Ltd and Inditherm Plc


http://www.medilinkwm.co.uk/news/display.php?id=455

RNS Number : 8668O
Mediwatch PLC
16 March 2009



Five year global distribution agreement secured with
Inverness Medical Innovations


Mediwatch plc ("Mediwatch" or "the Company", AIM: MDW), the innovative
urological diagnostic company, has signed a five-year agreement for the
worldwide distribution of PSAwatch, its flagship point-of-care total
PSA measuring system for prostate cancer, with Inverness Medical Innovations,
Inc. ("Inverness", NYSE: IMA) a leading provider of near-patient diagnostics,
monitoring and health management solutions.

This is a very important and substantial distribution agreement for Mediwatch as
Inverness has an extensive global sales-force which will complement Mediwatch's
own worldwide distribution network and provide the Company with considerably
more market reach. Inverness is recognised as a market leader with significant
expertise in marketing point-of-care tests, which they already manufacture for
other pathological conditions.

Prostate cancer is the second most common cause of cancer deaths with 670,000
men worldwide diagnosed with it annually. Approximately 10,000 men die every
year in the UK from prostate cancer with over 34,000 diagnosed with the disease
(Source: Cancer Research UK). There are 60 million PSA tests globally with
PSAwatch the first quantitative, point-of-care PSA test in this GBP300 million
market. It uses the Mediwatch Bioscan reader and therefore does not require
laboratories.

Philip Stimpson, Mediwatch Chief Executive commented'


"We are confident that this strategically important distribution agreement will
deliver a significant revenue stream. The market for point of care diagnostics
is growing rapidly as a result of a combination of; the population aging, growth
of local clinics, home testing and the need for faster, cheaper, more portable
and easier to use medical equipment.

"This is a significant development for Mediwatch as it means we can both
actively promote worldwide the early diagnosis of prostate cancer, with portable
rapid-testing equipment. This is particularly poignant and gratifying for us,
being a British company, as this is Prostate Cancer Awareness Month in the UK."

Some information on Inverness Medical Innovations:


Inverness Medical Innovations, Inc. (NYSE: IMA) is at the forefront of the convergence between medical diagnostic testing and health management. IMA is a major global developer, manufacturer and marketer of advanced, pioneering professional and consumer medical diagnostic products, as well as a leader in specialized health management services including wellness, disease management, oncology and women and children's health.

http://www.invernessmedical.com/

Along with MDW's own global distribution network the Inverness deal includes the following,which is nice! :-)

http://www.invernessmedical.com/inverness-worldwide/latin-america--africa.aspx

http://www.invernessmedical.com/inverness-worldwide/north-america.aspx

http://www.invernessmedical.com/inverness-worldwide/asia-pacific.aspx

http://www.invernessmedical.com/inverness-worldwide/europe--middle-east.aspx

So,Inverness have signed a 5 year deal for the distribution of PSAwatch before it has gained FDA approvals!

Therefore,Inverness must be confident that the FDA will approve PSAwatch as the US has the largest market for PSA testing at the present time.

Does this mean FDA approvals are arriving sooner rather than later? Or/and do Inverness see Africa for example,as an even bigger market?


Five year global distribution agreement secured with Inverness Medical Innovations

Mediwatch picks up global distribution deal with Inverness Medical Innovations


16 March 2009

Urological diagnostics group Mediwatch has signed a five-year agreement for the worldwide distribution of PSAwatch, its flagship point-of-care total PSA measuring system for prostate cancer, with US health company Inverness Medical Innovations, Inc.

Mediwatch described the deal as a very important and substantial distribution agreement because Inverness has an extensive global sales force which will complement Mediwatch's own worldwide distribution network and provide the company with considerably more market reach.

Philip Stimpson, Mediwatchs chief executive, commented: We are confident that this strategically important distribution agreement will deliver a significant revenue stream. The market for point of care diagnostics is growing rapidly as a result of a combination of; the population aging, growth of local clinics, home testing and the need for faster, cheaper, more portable and easier to use medical equipment.

This is a significant development for Mediwatch as it means we can both actively promote worldwide the early diagnosis of prostate cancer, with portable rapid-testing equipment.

http://www.smallcapnews.co.uk/article/Mediwatch_picks_up_global_distribution_deal_with_Inverness_Medical_Innovations/6942.aspx

still think it will test the lows again...i will be buying at about 5p if it gets there......risk/return at that level is good for me...at 8p it is not

LOL,
The chance to buy at sub 5p was there for all treblewide, you missed it though so just get on with it and buy some now (you know you want to :o)

The Cleveland Clinic event relating to 'Female Pelvic floor Disorders' finishes today and the next event MDW are exhibiting at is:


24th Annual EAU Congress Stockholm 17th - 21st March 2009

Scientific Programme

Oh,he's back again!

A repeat post but as the Stockholm EAU congress starts tomorrow......

"Not sure if Mark Emberton will be speaking at the Stockholm EAU congress as a non-executive Director of MDW or as an expert in the field of prostate cancer,probably the latter but all good publicity!

Prostate Cancer

Per-Anders Abrahamsson, Malm(SW), Frans M.J. Debruyne, Arnhem (NL), Mark Emberton, London (GB) and Manfred Wirth, Dresden (DE).

EAU TV is part of the EAU's initiatives to actively use contemporary electronic media such as podcast, webinars and TV news. For example, all congress sessions will be webcasted."

http://www.medicalnewstoday.com/articles/140822.php

nah dont think so minder...no man's land right now..i am stil expecitng 4k on the dow and i will be back into the stock market heavy and long term at they levels and not before...if i miss they levels then so be it...there will be other chances.

over and out

http://www.invernessmedical.com/inverness-worldwide/asia-pacific.aspx

I will have to look into China in more depth,another night but:

Chinese Markets for Prostate Cancer Treatment Drugs
Asia Market Information & Development Company
February 1, 2009

China's demand for Prostate Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-term forecasts throught 2013 and 2018 are presented. Major producers in China are profiled.


http://www.marketresearch.com/product/display.asp?productid=2090190&g=1





Diagnostic strategies and the incidence of prostate cancer: reasons for the low reported incidence of prostate cancer in China

Received 28 September 2008; Accepted 3 October 2008; Published online 1 December 2008.


Abstract

We have analysed the reasons for the low reported incidence of prostate cancer in China and argue for early diagnosis and treatment of this disease. According to the 2002 database of the International Agency for Research on Cancer (IARC), the age-standardized incidence of prostate cancer in China is 1.6/105 person years (PY), with a mortality rate of 1.0/105 PY and mortality-to-incidence rate ratio (MR/IR) = 0.63. The MR/IR ratio of prostate cancer in China was found to be higher than the average in Asia (MR/IR = 0.57) and much higher than that in North America (MR/IR = 0.13). These data indicate that in China most prostate cancers were in the advanced stages at the time of diagnosis, and that patients had a short survival time thereafter. In 2004, Stamey et al. reported a retrospective American study of prostate cancer for the years 1983-2003. It was shown that most cases of prostate cancer detected by prostate-specific antigen (PSA) screening were in the advanced stage at the start of this 20-year period. These early follow-up data are quite similar to the results obtained from mass PSA screening of elderly men in Changchun, China. However, after the American programmes for early diagnosis and treatment of prostate cancer were accepted, tumours were diagnosed at earlier stages. On the basis of these findings, mass screening should be performed in the whole of China using serum PSA to facilitate early diagnosis and treatment of prostate cancer.

http://www.asiaandro.com/v11/n1_abs_9.asp


Please do your own research at all times.Night

treblewide, yes if the DOW doesn't go to 4k then there will be lots of other chances LOL. Get real a degree of flexibility and reality required by you, but I think you have either fallen head overheels in love with the downside or you have no money to invest and are just pretending you count.

16/03/2009

Diagnostic specialist Mediwatch suggests its new distribution deal with leading US group Inverness Medical Innovations is the first of many deals.

New York-quoted Inverness, a world-leading maker of point-of-care medical tests, has signed a five-year agreement with AIM counter Mediwatch for the global distribution of the Rugby-based British companys flagship PSAwatch point-of-care measuring system for prostate cancer. Mediwatch, which specialises in urological disorders and already licences some of Invernesss technology, regards the PSAwatch deal, which brings it access to the US groups 1,000-strong sales force direct into GPs surgeries, as the precursor of more joint activities and the beginning of big things, says founder and chief executive Philip Stimpson, who recalls that the deal took two years to negotiate.

Mediwatch, which turned a 265,000 loss into pre-tax profits of 408,000 in the year to last October on turnover up 63% to 9.3m, is contemplating new joint ventures and alliances with other groups, says Stimpson. Company watchers expect some significant developments along these lines and even speculate about possible acquisitions before the end of the year.

http://www.growthcompany.co.uk/recommendations/1010802/mediwatch.thtml

minder..i think i have been really flexible....i was bearish on the stock and was proven correct i know want to buy but only where i see a good risk/reward ratio.

unlike you idiot perma-bulls who have been holding 50-60% losses on your holdings for years...now my friend that is being inflexible (and stupid) oh and ps if and when i do go long i will have a stop loss......i know you have not heard of it....go onto wikipedia..might save you a few quid old bean

treble,

I am not interested in anything you have to say and why your filtered,be off with you little boy.

Speaking of off,back at lunch.

lol........i was not talking to you ya daft old man...:-)

It must be noted that PSAwatch is not available in the US until FDA approvals are granted (due sometime this year) but news from the US has a major influence on the rest of the world,especially in the health sector.

Prostate cancer: A foe that can be defeated
BY Corky Siemaszko
DAILY NEWS STAFF WRITER

Tuesday, March 17th 2009, 4:00 AM

Few things are more chilling to men than the prospect of prostate cancer.

More than 200,000 new cases of prostate cancer will be diagnosed this year in the U.S. 10,500 in New York alone, experts say.

It is the second leading cause of death in American man nearly 30,000 will die of it this year.

Yet, prostate cancer is one of the most treatable forms of cancer if its caught in time.

If detected early, prostate cancer is curable, says Dr. Srikrishna Surasi, a urologist at Woodhull Hospital in Brooklyn.

That is why doctors recommend that men older than 40 especially African-American men and those with a family history of prostate cancer get their prostate checked annually.

All men older than 50 should also get a PSA test, which detects cancer by measuring the level of prostate-specific antigen in the bloodstream.


In the past six years, more than 120,000 New Yorkers have gotten free prostate exams courtesy of the Daily News and top medical professionals.

The News is planning to offer free PSA tests again this year, starting on Fathers Day.

http://www.nydailynews.com/lifestyle/health/2009/03/17/2009-03-17_prostate_cancer_a_foe_that_can_be_defeat.html

A bit old but still of interest and follows the general cancer trends of earlier posts regarding China and for that matter most of the world especially as modern ways of living/diet take a grip.


June 18, 2008

Movement Against Cancer Launches An All-Russia Cancer Awareness Campaign to Promote Early Screening and Cancer Detection Programs in Russia's Regions

MOSCOW, RUSSIA - Movement Against Cancer (MAC), cancer patient advocacy group in Russia, will conduct a public education campaign to urge people in Russia to undergo early screening tests and diagnostic procedures to detect breast cancer, colon cancer, stomach cancer, prostate cancer and cervical cancer - the types of cancer that could be cured if detected early.

One of the most serious problems with cancer treatment in Russia is a very low rate of early detection (stage I and stage II tumors), while in most cases the disease is diagnosed at very advanced stages when treatment options are less effective and much more costly. MAC efforts will be supported by the Russian government, which has launched a program to reduce cancer mortality rates.

http://www.cdi.org/russia/johnson/2008-119-45.cfm

Darth Vader treated for cancer
Tuesday, March 17, 2009, 16:39

The actor who played Darth Vader in the original Star Wars films has been treated for prostate cancer.
David Prowse, who wore the famous black suit and helmet to play the Dark Lord Of The Sith, rang Absolute Radio in an attempt to raise money for the Royal Marsden Hospital in London.
He told the Christian O'Connell Breakfast Show: "I'm involved with the Royal Marsden Hospital appeal because I'm undergoing treatment for prostate cancer, would you believe. I'm having my very last treatment this morning. I've had two months' radiotherapy treatment at the Royal Marsden. It's the most fantastic hospital you could ever wish to go to."
Prowse, 73, told the show he felt "fantastic".
"The only thing I've had is hot flushes and my wife tells me I'm going menopausal," he said.
"It's amazing what can be done so long as you catch it early. Every man over the age of 50 should have a PSA test (a blood test for prostate cancer) and that just gives you some indication of whether you have prostate problems."
James Earl Jones provided the voice for Vader in the films as Prowse's West Country accent was felt to be unsuitable for the part.


http://www.thisisbath.co.uk/showbiz/Darth-Vader-treated-cancer/article-776811-detail/article.html


The Brit is also well known in the U.K. for being the Green Cross Code Man, a superhero invented to promote a British road safety campaign for children in 1975.